Go ahead for new treatment for Black Bone Disease
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
When the weekly newsletter just isn't enough, discover more in this week's staff notices...
Our staff networks have been integral in progressing certain policies for LJMU staff, including on maternity leave and menopause.
PGRs attended 2 day residential writing event, at Gladstone's Library in Wales.
Public health experts at Liverpool John Moores University are looking into how lockdown has affected the physical and mental health of people in the North West.
Its been a tough year for LJMU's six hundred or so trainee teachers, but they will be uniquely skilled, argues Jan Rowe.
LJMU is one of 15 teams to win the Collaborative Award for Teaching Excellence (CATE) and an LJMU academic has also been awarded one of 54 National Teaching Fellows (NTF). Dr Philip Denton, Principal Lecturer at the School of Pharmacy and Biomolecular Sciences, is the recipient of the NTF and the paramedic team at LJMU’s Schools of Nursing and Allied Health received the CATE.
World-first: study demonstrates exercise promotes tumour regression in humans
Time is rapidly running out for Principal Investigators to be trained on the new Grants and Projects (GaP) system. It has been agreed by the University that any bids for external funding (research and enterprise activity) from April 2020 will need to be set up by the Principal Investigator on the GaP system, so its important that you book onto training ASAP.
Our next staff open day at the Student Life Building takes place on Wednesday 24 November, with networking opportunities, a chance to find out more about the building and its services, plus a free lunch.